Explore

TrendlineTrendline
Anaheim Bio Secures €40 Million Series A Funding to Advance Arthritis Treatment ANA-1

Anaheim Bio Secures €40 Million Series A Funding to Advance Arthritis Treatment ANA-1

Anaheim Bio Secures €40 Million Series A Funding to Advance Arthritis Treatment ANA-1
TrendlineTrendline
Commerce.com Reports Improved Profitability Outlook, Shares Rise 7%

Commerce.com Reports Improved Profitability Outlook, Shares Rise 7%

Commerce.com Reports Improved Profitability Outlook, Shares Rise 7%
TrendlineTrendline
Pinterest Reports Revenue Miss and Weak Holiday Guidance Due to EU Customs Rule Change

Pinterest Reports Revenue Miss and Weak Holiday Guidance Due to EU Customs Rule Change

Pinterest Reports Revenue Miss and Weak Holiday Guidance Due to EU Customs Rule Change
TrendlineTrendline
Agenus Reports Strong Third Quarter 2026 Results and Advances Phase 3 ROBBIN Study for Colon Cancer

Agenus Reports Strong Third Quarter 2026 Results and Advances Phase 3 ROBBIN Study for Colon Cancer

Agenus Reports Strong Third Quarter 2026 Results and Advances Phase 3 ROBBIN Study for Colon Cancer
TrendlineTrendline
Arcturus Therapeutics Reports Q3 2026 Financial Results and Advances mRNA Pipeline

Arcturus Therapeutics Reports Q3 2026 Financial Results and Advances mRNA Pipeline

Arcturus Therapeutics Reports Q3 2026 Financial Results and Advances mRNA Pipeline
TrendlineTrendline
Realty Income Raises Full-Year Guidance Amid European Expansion and Diversified Funding Strategy

Realty Income Raises Full-Year Guidance Amid European Expansion and Diversified Funding Strategy

Realty Income Raises Full-Year Guidance Amid European Expansion and Diversified Funding Strategy
TrendlineTrendline
Profound Medical Reports Strong Q3 2026 Results, Expands U.S. Distribution, and Announces Leadership Transition

Profound Medical Reports Strong Q3 2026 Results, Expands U.S. Distribution, and Announces Leadership Transition

Profound Medical Reports Strong Q3 2026 Results, Expands U.S. Distribution, and Announces Leadership Transition
ReutersReuters
Expedia shares slide as US-Iran war fallout prolongs pressure on travel firms

Expedia shares slide as US-Iran war fallout prolongs pressure on travel firms

By Nandan Mandayam and Anshuman Tripathy Nov 5 (Reuters) - Shares of Expedia Group tumbled nearly 13% on Thursday after the booking platform forecast earnings below estimates, joining travel companies from Hilton to Booking that continue to see the war in Iran scuttling demand.
TrendlineTrendline
AGCO Reports 9% Decline in Third Quarter Net Sales Amidst Mixed Regional Performance

AGCO Reports 9% Decline in Third Quarter Net Sales Amidst Mixed Regional Performance

AGCO Reports 9% Decline in Third Quarter Net Sales Amidst Mixed Regional Performance
TrendlineTrendline
Moderna Reports Q3 2026 Profit, Signaling Shift from Consistent Losses

Moderna Reports Q3 2026 Profit, Signaling Shift from Consistent Losses

Moderna Reports Q3 2026 Profit, Signaling Shift from Consistent Losses
ReutersReuters
Bombardier lifts 2026 free cash flow forecast, sees US trade risk easing

Bombardier lifts 2026 free cash flow forecast, sees US trade risk easing

By Allison Lampert and Megavarshini G.
TrendlineTrendline
Zai Lab Reports Third Quarter 2026 Financial Results and Pipeline Advancements

Zai Lab Reports Third Quarter 2026 Financial Results and Pipeline Advancements

Zai Lab Reports Third Quarter 2026 Financial Results and Pipeline Advancements